A Double-blind Crossover Study Comparing Prophylactic Intravenous Granisetron Alone or in Combination with Dexamethasone as Antiemetic Treatment in Controlling Nausea and Vomiting Associated with Chemotherapy

By Kirchner V.   Aapro M.   Terrey J.-P.   Alberto P.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1605-1610

Elsevier

Access to resources Recommend Favorite

The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy

By Carmichael James   Harris Adrian  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 123-128

Springer Publishing Company

Access to resources Recommend Favorite

Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study

By Fotopoulou Christina   Hee Cho Chie   Kraetschell Robert   Gellermann Johanna   Wust Peter   Lichtenegger Werner   Sehouli Jalid  

International Journal of Hyperthermia, Vol. 26, Iss. 2, 2010-05 ,pp. : 118-126

Informa Healthcare

Access to resources Recommend Favorite

A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

By on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 807-813

Elsevier

Access to resources Recommend Favorite

Low-Dose Oral Granisetron (1 mg) plus Intravenous Dexamethasone: Efficacy in Gynecologic Cancer Patients Receiving Carboplatin-Based Chemotherapy

By Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 113-115

Elsevier

Access to resources Recommend Favorite